You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XLO Award Disclosure
Houvras Yariv · SEC Form 4 · Filed Oct 2, 2026
Award
Calculated transaction value
$0
Houvras Yariv Chief Medical Officer
XLO
Transaction date
Oct 1, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 1 day later
XLO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 105,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-412466
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Xilio Therapeutics, Inc. XLO Current | Award | Oct 1, 2026 | $0 |